Fundraising FoxGLUCOSENTIENT INC
1 known investors
Find your way into GLUCOSENTIENT INC
Sign up to see every warm intro you have to GLUCOSENTIENT INC
- Paths you didn't know you had: your email and LinkedIn already hold routes to the GLUCOSENTIENT INC team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
GlucoSentient develops diagnostic assays based on functional DNA (DNAzymes and aptamers) and nanomaterials for sensing applications. The company applies this biosensing technology to the diagnostics and medical testing field.
Founders & leadership
YL
Yi LuFounder & Scientific Advisor
TL
Tian LanTechnical Lead
SM
Steve Mayer
Investors · 1
Non-dilutive funding · 10 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $269K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $224K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2018 | $1.4M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $225K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $223.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2016 | $211K |
| National Science Foundation | Phase II | 2013 | $750K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2013 | $193K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2013 | $136.8K |
| National Science Foundation | Phase I | 2012 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does GLUCOSENTIENT INC do?
- GlucoSentient develops diagnostic assays based on functional DNA (DNAzymes and aptamers) and nanomaterials for sensing applications. The company applies this biosensing technology to the diagnostics and medical testing field.
- Who founded GLUCOSENTIENT INC?
- GLUCOSENTIENT INC was founded by Yi Lu.
- Who are GLUCOSENTIENT INC's investors?
- GLUCOSENTIENT INC's investors include Serra Ventures.